Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Moderna stock is under pressure, again, as Robert F. Kennedy Jr. reportedly mulls pulling the company's federal funding to ...

Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts, in the form of a patent infringement lawsuit.

Citi initiated coverage of Moderna (MRNA) with a Neutral rating and $40 price target Healthcare policy remains a key biopharma sector ...

March 5, 2025 Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on ...

Today, we are looking at therapeutics stocks, starting with Myriad Genetics (NASDAQ:MYGN). Moderna (NasdaqGS:MRNA) recently faced significant legal challenges with five international lawsuits from ...

The best kids' water bottles become a staple in every parent's armoury, not to mention a requirement for most children to take to school and nursery. We recruited primary school children to help with ...

This week marks the fifth anniversary of the pandemic. What are your most lasting memories? How has it shaped your life and the world around you? By Jeremy Engle What do you notice about the ...

Vaccine bottles. Image by Prefeitura de Itapevi, Public domain, via Wikimedia Commons. Introduced in 1963, the measles vaccine significantly reduced cases and fatalities associated with the disease.

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy.